controversy about using glyburide for type 2 diabetes

April 2009

There's controversy about using glyburide for type 2 diabetes.

It's commonly used, but it's often not the best sulfonylurea.

That's because glyburide is longer-acting and causes more hypoglycemia than other second-generation sulfonylureas.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix)
Antidepressants new antidepressant called Pristiq (desvenlafaxine)
Antithrombotics when and how to use vitamin K to reverse the effects of warfarin
Gastroenterology new version of pantoprazole called Tecta
Gastroenterology risk for tardive dyskinesia with metoclopramide
Respiratory & Allergy patients on topical nasal decongestants (oxymetazoline, etc) get rebound congestion
Practice How should you handle an Rx written for the prescriber's personal or family use
Diabetes controversy about using glyburide for type 2 diabetes
Psychiatry how to treat dementia associated with Parkinson's
Psoriasis Raptiva (efalizumab) sales are now suspended in Canada due to the risk of fatal opportunistic infections
Pediatrics new vaccine called Infanrix-hexa that gives SIX vaccines in ONE shot
Pediatrics treating constipation in children
Infectious Diseases LESS cross-sensitivity between penicillins and carbapenems than we think